» Articles » PMID: 28934902

Pregnancy-related Outcomes for Women with Polycystic Ovary Syndrome

Overview
Date 2017 Sep 23
PMID 28934902
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The polycystic ovary syndrome is a common endocrine disorder that has profound implications for women throughout their reproductive years. A diagnosis of polycystic ovary syndrome is associated with reproductive challenges including a difficulty in conceiving as well as the pregnancy-related complications of miscarriage, hypertensive disorders, gestational diabetes and prematurity. Consequently, polycystic ovary syndrome has profound implications for women and their offspring with regard to reproductive function in the short term and in the longer term the risk of chronic illness and congenital anomalies, and health care resources should be directed accordingly to mitigate against these risks.

Citing Articles

Individualised Lifestyle Intervention in Polycystic Ovarian Syndrome Women Who Desire Fertility: A Feasibility Study.

Koduri P, Parimala C, Kunjummen A, Yadav B, Kapoor N, Sandhiya P J Hum Reprod Sci. 2024; 17(3):207-215.

PMID: 39544680 PMC: 11559350. DOI: 10.4103/jhrs.jhrs_111_24.


Competence of Combined Low Dose of Human Chorionic Gonadotropin (HCG) and Clomiphene Citrate (CC) Versus Continued CC during Ovulation Induction in Women with CC-Resistant Polycystic Ovarian Syndrome: A Randomized Controlled Trial.

Thabet M, Abdelhafez M, Elshamy M, Albahlol I, Fayala E, Wageeh A Medicina (Kaunas). 2024; 60(8).

PMID: 39202581 PMC: 11356540. DOI: 10.3390/medicina60081300.


Polycystic ovary syndrome and chronic pain among females and individuals of childbearing age: A scoping review.

Sacca L, Okwaraji G, Densley S, Marciniak A, Knecht M, Wilson C SAGE Open Med. 2024; 12:20503121241262158.

PMID: 38903491 PMC: 11189018. DOI: 10.1177/20503121241262158.


Early- to mid-gestational testosterone excess leads to adverse cardiac outcomes in postpartum sheep.

Alkhatib B, Ciarelli J, Ghnenis A, Pallas B, Olivier N, Padmanabhan V Am J Physiol Heart Circ Physiol. 2024; 327(2):H315-H330.

PMID: 38819385 PMC: 11687963. DOI: 10.1152/ajpheart.00763.2023.


Polycystic Ovary Syndrome and Irritable Bowel Syndrome: Is There a Common Pathway?.

Saei Ghare Naz M, Ghasemi V, Amirshekari S, Ramezani Tehrani F Endocrinol Diabetes Metab. 2024; 7(2):e00477.

PMID: 38494583 PMC: 10944984. DOI: 10.1002/edm2.477.


References
1.
Maliqueo M, Sundstrom Poromaa I, Vanky E, Fornes R, Benrick A, Akerud H . Placental STAT3 signaling is activated in women with polycystic ovary syndrome. Hum Reprod. 2015; 30(3):692-700. DOI: 10.1093/humrep/deu351. View

2.
Joham A, Teede H, Ranasinha S, Zoungas S, Boyle J . Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study. J Womens Health (Larchmt). 2015; 24(4):299-307. DOI: 10.1089/jwh.2014.5000. View

3.
Joham A, Palomba S, Hart R . Polycystic Ovary Syndrome, Obesity, and Pregnancy. Semin Reprod Med. 2016; 34(2):93-101. DOI: 10.1055/s-0035-1571195. View

4.
Palomba S, Falbo A, Russo T, Tolino A, Orio F, Zullo F . Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes. Fertil Steril. 2009; 94(5):1805-11. DOI: 10.1016/j.fertnstert.2009.10.043. View

5.
Kollmann M, Klaritsch P, Martins W, Guenther F, Schneider V, Herzog S . Maternal and neonatal outcomes in pregnant women with PCOS: comparison of different diagnostic definitions. Hum Reprod. 2015; 30(10):2396-403. DOI: 10.1093/humrep/dev187. View